1. Defining Dental Mesenchyme Subgroups at Different Developmental Stages in the Integrated Single-Cell Transcriptomic Atlas
Data cleaning and clustering analyses were conducted on GSE189381 in a manner similar to that described in a previously published study on cranial neural crest cells24. The single-cell RNA sequencing data underwent preprocessing steps, including quality control, integration, principal component analysis, and dimensionality reduction. UMAP plots (Figure 1A) were used to visually represent the single-cell data from E13.5 to PN7.5 in the tooth and surrounding tissue. Based on further subcluster analyses and known markers for dental mesenchyme, the dental mesenchyme subcluster was identified in each UMAP plot, denoted by a dotted frame (Figure 1B).
At E13.5, the early stage of tooth development, the major clusters were classified into two categories: dental mesenchyme and epithelial cell clusters. By E14.5, two distinct clusters representing dental follicle and dental papilla cells were observed, suggesting lineage segregation at this stage. At E16.5, the dental follicle differentiated into lateral and apical follicles, while the dental papilla formed separate coronal and apical papillae. When reaching PN3.5, nearing the onset of root development, the follicle differentiation pattern displayed similarities to that seen at E16.5, whereas the papilla subclusters included coronal papilla, middle papilla, apical papilla, and odontoblast clusters. Finally, at PN7.5, the cell population resembled that at PN3.5, indicating the likely completion of tooth root development. Notably, Slit3 exhibited constant expression in the dental mesenchyme subclusters, while showing minimal to no expression in the epithelial cell subcluster.
2. SLIT3 is continuously expressed in odontoblasts of developing mandibular first molar in mice.
In immunohistochemical staining of paraffin sections of the first mandibular molar tissues of PN1 mice, SLIT3 was expressed in odontoblasts, ameloblasts, and the middle layer (Figure 1C). On PN7, SLIT3 was expressed in the dental papilla, odontoblasts, ameloblasts and the middle layer (Figure 1D). In PN14 mice, SLIT3 was expressed in the odontoblast layer (Figure 1E), but not in other sites. In the immunohistochemical staining results of tissue sections of PN21 mice, SLIT3 was expressed in both crown and root odontoblasts, and the expression of SLIT3 was stronger in root odontoblasts (Figure 1E and F). In conclusion, SLIT3 is not only positively expressed in the tooth embryo, but also continuously expressed in odontoblasts during the development of mouse mandibular molars, suggesting that SLIT3 plays an important role in the differentiation and maturation of odontoblasts and the formation of hard tissues.
3. Increased gene and protein expression of SLIT3 during odontogenic differentiation of SCAP.
In this study, SCAP was isolated from an undeveloped caries-free third molar. In the process of mineralization medium induced odontogenic differentiation of SCAP, RT-PCR results indicated that the expression of SLIT3 RNA in the experimental group was significantly increased (P < 0.05), which was statistically different from that in the control group, and the difference became more obvious as time went on (P < 0.0001) (Figure 1G). Western blot results also indicated that the protein expression level of SLIT3 in the experimental group was also higher than that in the control group during the odontogenic differentiation of SCAP (Figure 1H). In the microarray dataset, Slit3 was found to be highly expressed in both the buccal dental follicle group and the lingual dental papilla group, while its expression was lower in both the buccal and lingual dental epithelial group (Figure 1I).
4. SLIT3 can promote the proliferation of SCAP.
SCAP with low/high expression of SLIT3 were simulated in vitro. The results of RT-PCR indicated that SLIT3 expression in SLIT3 siRNA group was significantly lower than NC group, while the expression of SLIT3 in rhSLIT3 treated group was significantly higher than control group (Figure 2A and Figure 2B). It is credible that the SCAP with low/high expression of SLIT3 can be used for the detection of subsequent experiments.
Then, we used CCK8 kit to detect the effect of SLIT3 expression on the proliferation of SCAP (Figure 2C). The results suggested that proliferation of SCAP was enhanced when the expression of SLIT3 was increased, but was weakened in cells with low SLIT3 expression, which proved that SLIT3 could promote the proliferation of SCAP.
5. SLIT3 could promote the mineralization of SCAP and up-regulate the expression of DMP-1 and DSPP.
In the SCAP with low expression of SLIT3, after mineralization induction for 7 days, the ALP staining results showed that the staining degree of SLIT3 siRNA group was lighter than negative control group (Figure 3A). After mineralization induction for 14 days, the ARS staining results also revealed that the mineralized nodules of SLIT3 siRNA group was less than negative control group (Figure 3B), indicating that the odontogenic differentiation ability of SCAP was inhibited followed the decrease of SLIT3 expression.
In the SCAP with rhSLIT3 treated, after mineralization induction for 7 days, the ALP staining results revealed that the degree of mineralization of rhSLIT3 group was higher than the control group (Figure 3H). After mineralization induction for 14 days, the ARS staining results also revealed that the degree of mineralization of rhSLIT3 group was higher than the control group (Figure 3I), indicating that the odontogenic differentiation ability of SCAP was promoted after the increase of SLIT3 expression.
In order to further verify that whether SLIT3 can promote the odontogenic differentiation of SCAP, RT-PCR and Western blot were used to detect the effect of SLIT3 on the expression of dentin formation markers. The RNA and protein samples of SCAP with low/high expression of SLIT3 were collected on the 7th, 10th and 14th day after mineralization induction. The results of RT-PCR demonstrated that the expression of DMP-1 and DSPP decreased in siRNA group, while the expression level of DMP-1 and DSPP was elevated after the increase of SLIT3 in rhSLIT3 group (Figure 3C, D, J and K). The results of Western blot also demonstrated that after 7, 10 and 14 days of mineralization induction, the protein expression of DMP-1 and DSPP decreased in siRNA group, while the protein expression of DMP-1 and DSPP increased in rhSLIT3 group (Figure 3E, F, G, L, M and N).
6. SLIT3 can activate Akt/Wnt/β-catenin signaling pathway leading to the promotion of odontogenic differentiation of SCAP.
In our study, we found that SLIT3 could activate Akt/Wnt/β-catenin signaling pathway. SLIT3 could regulate the activity of pivotal signaling molecule, like Akt, GSK3β and β-catenin, of Akt/Wnt/β-catenin pathway, and ultimately lead to the activation of target genes in the nucleus (Figure 6D), thus exerting its ability to promote the odontogenic differentiation of SCAP. When Akt/Wnt/β-catenin signaling pathway was blocked, the effect of SLIT3 on odontogenic differentiation of SCAP was cancelled.
a) SLIT3 can promote the phosphorylation of Akt and GSK-3β in SCAP.
After the addition of recombinant human SLIT3 protein, the results of Western blot suggested that the levels of p-Akt and p-GSK3β in SCAP were significantly increased after 30- and 60-minutes stimulation (Figure 4A, B and C) respectively, indicating that SLIT3 can activate and phosphorylate Akt after binding to the receptors on the cell membrane, and then promote the phosphorylation of GSK3β, resulting in the inactivation of GSK3β.
b) SLIT3 can reduce the degradation of β-catenin and promote its nuclear translocation.
After the stimulation of rhSLIT3 protein for 60 mins or later, the results of Western blot revealed that the level of β-catenin in the nucleus of SCAP significantly increased, especially at 90min and 120min (Figure 5A and B). It is suggested that SLIT3 can lead to the accumulation of β-catenin in the nucleus of SCAP.
In order to further clarify the changes of β-catenin in SCAP after the stimulation of rhSLIT3 protein, we localized the distribution of β-catenin in SCAP by cellular immunofluorescence staining (Figure 4C). The results suggested that β-catenin accumulated gradually in SCAP after stimulation for 60 minutes, and a small part of β-catenin transferred into the nucleus. After stimulation for 90 minutes, β-catenin was still accumulating and the level of β-catenin in nucleus increased gradually. After stimulation for 120 minutes, β-catenin continued to accumulate in the SCAP and more β-catenin transferred into the nucleus. These results indicated that SLIT3 can inhibit the degradation of β-catenin in SCAP, making it accumulate and transfer into the nucleus to play a regulatory role.
c) The promotion of SLIT3 on odontogenic differentiation of SCAP was cancelled after inhibition of Akt/Wnt/β-catenin signaling pathway.
After blocking Akt/Wnt/β-catenin signaling pathway with inhibitor Resibufogenin, we explored whether the effect of SLIT3 on odontogenic differentiation of SCAP was changed. The results of RT-PCR and Western blot demonstrated that the expression of dentin formation markers, DMP-1 and DSPP, was decreased after adding inhibitor Resibufogenin, which suggested that the odontogenic differentiation ability of SCAP was inhibited. When Resibufogenin and rhSLIT3 protein were added at the same time, the expression of DMP-1 and DSPP was not significantly up-regulated compared with only adding Resibufogenin, indicating that the effect of SLIT3 on promoting odontogenic differentiation of SCAP was cancelled (Figure 6A, B and C). The above results proved that SLIT3 could promote the odontogenic differentiation of SCAP through Akt/Wnt/β-catenin signaling pathway (Figure 6D).